Renaissance Technologies LLC Has $13.75 Million Position in Addus HomeCare Co. (NASDAQ:ADUS)

Renaissance Technologies LLC cut its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 10.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 109,700 shares of the company’s stock after selling 13,000 shares during the period. Renaissance Technologies LLC owned 0.61% of Addus HomeCare worth $13,751,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in ADUS. Smartleaf Asset Management LLC increased its position in Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock worth $35,000 after buying an additional 214 shares during the period. Parkside Financial Bank & Trust grew its stake in shares of Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after acquiring an additional 148 shares during the last quarter. Meeder Asset Management Inc. bought a new position in Addus HomeCare during the fourth quarter worth $77,000. Harvest Fund Management Co. Ltd acquired a new position in Addus HomeCare during the 4th quarter valued at $86,000. Finally, KBC Group NV boosted its holdings in Addus HomeCare by 49.1% in the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after purchasing an additional 268 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Price Performance

Shares of ADUS stock opened at $102.17 on Tuesday. The stock’s fifty day simple moving average is $100.73 and its 200 day simple moving average is $117.77. Addus HomeCare Co. has a one year low of $87.88 and a one year high of $136.72. The firm has a market cap of $1.86 billion, a price-to-earnings ratio of 23.38, a P/E/G ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. On average, research analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on ADUS shares. StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Stephens restated an “overweight” rating and set a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Oppenheimer lifted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, Macquarie restated an “outperform” rating and issued a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $132.78.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.